Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Foot-and-mouth disease virus serotype A (FMDV-A) is a highly contagious pathogen belonging to the Aphthovirus genus of the Picornaviridae family [1, 8]. It is one of the seven major serotypes responsible for foot-and-mouth disease, a severe vesicular condition affecting cloven-hoofed animals such as cattle, pigs, and sheep [4, 12]. The virus consists of a positive-sense single-stranded RNA genome enclosed in a non-enveloped icosahedral capsid [8, 13]. FMDV-A initiates infection by binding to host cell integrin receptors via a conserved Arg-Gly-Asp (RGD) motif on its VP1 capsid protein [2, 14]. Once inside the host cell, the viral genome is translated into a single polyprotein that is subsequently cleaved by viral proteases, including the 3C protease, into functional structural and non-structural proteins [8, 16]. Therapeutic interventions primarily involve the use of inactivated virus vaccines, which are often serotype-specific due to the high rate of antigenic variation [5, 15]. Experimental antiviral drugs, such as ribavirin and specific protease inhibitors, are also being investigated to target viral replication and processing [11, 16]. Control of FMDV-A is critical for the livestock industry due to its rapid transmission and the significant economic impact of outbreaks [10, 20].
Inhibition of RNA-dependent RNA polymerase (3Dpol), inhibition of viral 3C protease, and neutralization of viral capsid proteins to prevent host cell entry.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Foot-and-mouth disease virus serotype A (FMDV-A).